Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boehringer Elecsys 1998 gross sales projected at $150 mil. -- Igen breach of contract lawsuit.

This article was originally published in The Gray Sheet

Executive Summary

IGEN SEEKS TERMINATION OF BOEHRINGER ECL LICENSING AGREEMENT in a complaint filed Sept. 15 with the Circuit Court for Montgomery County, Maryland. Igen alleges that Boehringer Mannheim has failed to meet its royalty obligations and violated other terms of a 1992 license and technology development pact. The agreement gave Boehringer exclusive rights to immunoassay applications of Igen's Origen electrochemiluminescence technology and semi-exclusive rights to ECL for use in nucleic acid-probe products.
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT008817

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel